Roku, Inc. Class A Common Stock aka ROKU

ROKU Current Situation

  • Hold cash

ROKU Plot with Buy and Sell Trade Signals

  • ROKU open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-01-18
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for Roku, Inc. Class A Common Stock  (ROKU)

Cumulative Trading Results for Roku, Inc. Class A Common Stock  (ROKU)

Cumulative Benchmark Buy and Hold Results for Roku, Inc. Class A Common Stock  (ROKU)

ROKU Trading Results

Total Percentage Period
-10.84 3 Months
54.58 6 Months
122.92 9 Months
0.00 YTD Months
151.99 12 Months
130.24 24 Months
107.88 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for ROKU was used as the benchmark

PDCO Patterson Companies, Inc. Common Stock aka PDCO

PDCO Current Situation

  • Hold stock

PDCO Plot with Buy and Sell Trade Signals

  • PDCO open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-01-18
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for 
PDCO
Patterson Companies, Inc. Common Stock
 (PDCO)

Cumulative Trading Results for 
PDCO
Patterson Companies, Inc. Common Stock
 (PDCO)

Cumulative Benchmark Buy and Hold Results for 
PDCO
Patterson Companies, Inc. Common Stock
 (PDCO)

PDCO Trading Results

Total Percentage Period
14.02 3 Months
20.93 6 Months
16.40 9 Months
0.00 YTD Months
13.14 12 Months
11.19 24 Months
11.19 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for PDCO was used as the benchmark

IMMU Immunomedics, Inc. Common Stock aka IMMU

IMMU Current Situation

  • Hold cash

IMMU Plot with Buy and Sell Trade Signals

  • IMMU open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-01-18
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for 
IMMU
Immunomedics, Inc. Common Stock
 (IMMU)

Cumulative Trading Results for 
IMMU
Immunomedics, Inc. Common Stock
 (IMMU)

Cumulative Benchmark Buy and Hold Results for 
IMMU
Immunomedics, Inc. Common Stock
 (IMMU)

IMMU Trading Results

Total Percentage Period
14.37 3 Months
23.48 6 Months
37.37 9 Months
-2.22 YTD Months
56.88 12 Months
84.58 24 Months
80.76 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for IMMU was used as the benchmark

HIBB Hibbett Sports, Inc. Common Stock aka HIBB

HIBB Current Situation

  • Hold stock

HIBB Plot with Buy and Sell Trade Signals

  • HIBB open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-01-18
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for 
HIBB
Hibbett Sports, Inc. Common Stock
 (HIBB)

Cumulative Trading Results for 
HIBB
Hibbett Sports, Inc. Common Stock
 (HIBB)

Cumulative Benchmark Buy and Hold Results for 
HIBB
Hibbett Sports, Inc. Common Stock
 (HIBB)

HIBB Trading Results

Total Percentage Period
-11.41 3 Months
14.30 6 Months
21.33 9 Months
0.00 YTD Months
28.91 12 Months
12.95 24 Months
63.20 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for HIBB was used as the benchmark

EVER EverQuote, Inc. Class A Common Stock aka EVER

EVER Current Situation

  • Hold stock

EVER Plot with Buy and Sell Trade Signals

  • EVER open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-01-18
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for 
EVER
EverQuote, Inc. Class A Common Stock
 (EVER)

Cumulative Trading Results for 
EVER
EverQuote, Inc. Class A Common Stock
 (EVER)

Cumulative Benchmark Buy and Hold Results for 
EVER
EverQuote, Inc. Class A Common Stock
 (EVER)

EVER Trading Results

Total Percentage Period
78.77 3 Months
84.47 6 Months
94.79 9 Months
0.00 YTD Months
143.78 12 Months
179.30 24 Months
179.30 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for EVER was used as the benchmark

CNST Constellation Pharmaceuticals, Inc. Common Stock aka CNST

CNST Current Situation

  • Buy

CNST Plot with Buy and Sell Trade Signals

  • CNST open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-01-18
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for 
CNST
Constellation Pharmaceuticals, Inc. Common Stock
 (CNST)

Cumulative Trading Results for 
CNST
Constellation Pharmaceuticals, Inc. Common Stock
 (CNST)

Cumulative Benchmark Buy and Hold Results for 
CNST
Constellation Pharmaceuticals, Inc. Common Stock
 (CNST)

CNST Trading Results

Total Percentage Period
166.38 3 Months
204.82 6 Months
199.91 9 Months
0.00 YTD Months
278.31 12 Months
291.13 24 Months
291.13 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for CNST was used as the benchmark

BEIGENE ADR REP aka BGNE

BGNE Current Situation

  • Hold stock

BGNE Plot with Buy and Sell Trade Signals

  • BGNE open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-01-18
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for BEIGENE ADR REP (BGNE)

Cumulative Trading Results for BEIGENE ADR REP (BGNE)

Cumulative Benchmark Buy and Hold Results for BEIGENE ADR REP (BGNE)

BGNE Trading Results

Total Percentage Period
-3.74 3 Months
72.14 6 Months
73.11 9 Months
0.00 YTD Months
91.74 12 Months
128.82 24 Months
220.81 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for BGNE was used as the benchmark

Axsome Therapeutics, Inc. Common Stock aka AXSM

AXSM Current Situation

  • Hold stock

AXSM Plot with Buy and Sell Trade Signals

  • AXSM open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-01-18
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for Axsome Therapeutics, Inc. Common Stock  (AXSM)

Cumulative Trading Results for Axsome Therapeutics, Inc. Common Stock  (AXSM)

Cumulative Benchmark Buy and Hold Results for Axsome Therapeutics, Inc. Common Stock  (AXSM)

AXSM Trading Results

Total Percentage Period
158.17 3 Months
175.44 6 Months
189.47 9 Months
0.00 YTD Months
256.06 12 Months
489.10 24 Months
454.76 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for AXSM was used as the benchmark

Arrowhead Pharmaceuticals, Inc. Common Stock aka ARWR

ARWR Current Situation

  • Hold cash

ARWR Plot with Buy and Sell Trade Signals

  • ARWR open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-01-18
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for Arrowhead Pharmaceuticals, Inc. Common Stock  (ARWR)

Cumulative Trading Results for Arrowhead Pharmaceuticals, Inc. Common Stock  (ARWR)

Cumulative Benchmark Buy and Hold Results for Arrowhead Pharmaceuticals, Inc. Common Stock  (ARWR)

ARWR Trading Results

Total Percentage Period
57.79 3 Months
96.04 6 Months
119.81 9 Months
0.00 YTD Months
138.28 12 Months
223.18 24 Months
242.73 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for ARWR was used as the benchmark

Roku, Inc. Class A Common Stock aka ROKU

ROKU Current Situation

  • Hold cash

ROKU Plot with Buy and Sell Trade Signals

  • ROKU open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-01-17
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for Roku, Inc. Class A Common Stock  (ROKU)

Cumulative Trading Results for Roku, Inc. Class A Common Stock  (ROKU)

Cumulative Benchmark Buy and Hold Results for Roku, Inc. Class A Common Stock  (ROKU)

ROKU Trading Results

Total Percentage Period
-10.84 3 Months
54.58 6 Months
122.92 9 Months
0.00 YTD Months
151.99 12 Months
130.24 24 Months
107.88 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for ROKU was used as the benchmark